EUROPEAN CYSTIC FIBROSIS SOCIETY

44th European Cystic Fibrosis Conference

 

9-12 June 2021 Digital Conference
Close
N. Poster
Poster title
Applicant name
Status
  EPS2-001 Drug-induced liver injury from antibiotics administered to adult cystic fibrosis patients: is it a problem? A single-centre retrospective study Rachael Meredith Received Received
  EPS3-001 Is variation in Pseudomonas aeruginosa (Pa) surface-enhanced Raman spectroscopy (SERS) spectra related to phenotype? Danielle Allen Received Received
  EPS1-001 Physiotherapy practice of French cystic fibrosis children changed during lockdown due to COVID-19 pandemic Marie Mittaine Received Received
  P-001 TCR repertoire in monozygotic cystic fibrosis twins Burkhard Tmmler Received Received
  P-002 Genetic characteristics of the cystic fibrosis Polish patients registered in the public Matio Polish Cystic Fibrosis Foundation Karolina Surma Received Received
  EPS3-002 Using rapid evaporative ionisation mass spectrometry (REIMS) for biomarker discovery and mechanistic studies of Pseudomonas aeruginosa stress responses Rob Bradley Received Received
  EPS1-002 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK Catherine Brown Received Received
  EPS3-003 Using airway organoids and Air Liquid Interface cultures to profile the spatial and temporal dynamics of Pseudomonas aeruginosa infections Signe Lolle Received Received
  EPS1-003 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis Elpis Hatziagorou Received Received
  EPS2-003 Lumacaftor-ivacaftor therapy and its impact on glucose tolerance in children with cystic fibrosis Kathy McGrath Received Received
  EPS3-004 Depolarisation of the Pseudomonas aeruginosacytoplasmic membrane by Glatiramer acetate potentiates the antibacterial activity of tobramycin Ronan Murphy Received Received
  EPS1-004 Audit of virtual exercise class during COVID-19 in children with cystic fibrosis Zoe Johnstone Received Received
  EPS2-004 The role of Flash Glucose Monitoring System at annual review during the COVID-19 restrictions, within Cystic Fibrosis Diabetes Service at Blackpool Adult Cystic Fibrosis Centre. UK Julie Knowles Received Received
  EPS2-005 Arm circumference and skinfolds vs. body mass index: a single-centre experience over two decades Dorothea Appelt Received Received
  EPS1-005 Evaluating impacts of the change from clinic to home spirometry on clinicians and adults with cystic fibrosis Tracey Daniels Received Received
  P-005 Mild variants of the CFTR gene in Russian patients without clinical manifestations Yuliya Melyanovskaya Received Received
  P-006 The complex allele c.1399CT;1521_1523delCTT (L467F;F508del) of the CFTR gene in Russian cystic fibrosis patients Nataliya Kashirskaya Received Received
  EPS3-006 Low induction of Antibiotic resistance by two new drugs against Pseudomonas aeruginosa in a clinical cohort of cystic fibrosis patients Mette Kolpen Received Received
  EPS2-006 What do people with cystic fibrosis eat? Diet quality, macronutrient and micronutrient intakes compared to recommended guidelines in adults with cystic fibrosis: a systematic literature review Nicola Drummond Received Received
  EPS1-006 A retrospective audit of home-based spirometry quality in a large UK adult cystic fibrosis centre Ian Waller Received Received
  P-007 A novel cystic fibrosis-causing mutation identified in a newborn of African origin Natalia Cirilli Received Received
  EPS1-007 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics Emily Scott Received Received
  EPS2-007 How did the COVID-19 lockdown influence the nutritional status and body composition of cystic fibrosis patients in Poland? Monika Mielus Received Received
  EPS3-007 Predictors of eradication failure at first isolation of MRSA in children with cystic fibrosis Almala Pinar Ergenekon Received Received
  EPS2-008 The model for determining risk groups for the development of vitamin D deficiency and prevention algorithm in children with cystic fibrosis using the multifactor dimensionality reduction method Elena Zhekaite Received Received
  P-008 Identification of two novel mutations (c.3639dup and ex16-17a dup) in the CFTR gene in Polish patient with cystic fibrosis Sebastian Wardak Received Received
  EPS3-008 Evaluation of a fixed-step eradication regime in children with cystic fibrosis and detection of Pseudomonas aeruginosa Simon Florian Grewendorf Received Received
  EPS1-008 Exercising online a Beaming good initiative Gemma McCrea Received Received
  EPS3-009 Biofilm formation in methicillin-resistant Staphylococcus aureus isolated in cystic fibrosis patients is strain-dependent and differentially influenced by antibiotics Agathe Boudet Received Received
  P-009 The investigation of the effect of electrolyte disorder on sweat test in newborns with positive cystic fibrosis screening test Sevgi Pekcan Received Received
  EPS2-009 F508del genotype is an independent risk factor for reduced bone mineral density in children with cystic fibrosis JASNA RODMAN BERLOT Received Received
  EPS1-009 Adapting services during the COVID-19 pandemic a patient evaluation of physiotherapy telephone reviews within multidisciplinary team virtual clinics Sarah Fitzgerald Received Received
  P-010 Newborn screening for cystic fibrosis improves nutritional outcome: monocentric data of the first 4 years in Germany Katharina Schtz Received Received
  EPS2-010 Pregnancy and cystic fibrosis: patients experience from pre-conception to birth Marilyn Hagan Received Received
  EPS3-010 Clinical pharmacokinetics and dose recommendations for posaconazole gastro-resistant tablets in children with cystic fibrosis Sian Bentley Received Received
  P-011 Cystic fibrosis - newborn screening (CF-NBS) start-up in Flanders (Belgium): report of first evaluation after two years Marijke Proesmans Received Received
  P-012 Two years neonatal screening for cystic fibrosis in Republic of North Macedonia Stojka Fustik Received Received
  P-013 Evaluation of improvements of the cystic fibrosis newborn screening protocol in the Netherlands Marelle Bouva Received Received
  P-015 Evaluation of the specificity and sensitivity of the cut-off values of immunoreactive trypsinogen in the cystic fibrosis newborn screening program Tugba Ramasli Gursoy Received Received
  P-016 The role of clinical and laboratory findings in the diagnosis of cystic fibrosisin children with positive newborn screening Tugba Ramasli Gursoy Received Received
  P-017 Different ethnical distribution of the incidence of cystic fibrosis in Republic of North Macedonia Violeta Anastasovska Received Received
  P-018 Follow-up of children with Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) in Switzerland Orell Imahorn Received Received
  P-019 Inconclusive Cystic Fibrosis Positive Neonatal Screening (CFSPID): clinical outcomes Silvia Gartner Received Received
  P-020 CFTR mutation panel in detecting cystic fibrosis screen positive inconclusive diagnosis patients (CFSPIDs) in the Marche Region, Italy Natalia Cirilli Received Received
  P-021 An evaluation of the cystic fibrosis newborn screening service at Royal Manchester Childrens Hospital - experience from a tertiary service provider in Northwest United Kingdom Anirban Maitra Received Received
  P-022 Evaluation of hearing and vestibular system in patients with cystic fibrosis Beste zsezen Received Received
  P-023 Characterisation of CFTR function in a patient with the F508del/CFTRdup1-3 genotype Senne Cuyx Received Received
  P-024 Pili annulati: is it a new finding in cystic fibrosis? SEVG&304; PEKCAN Received Received
  P-025 Systems biology modelling of CFTR maturation to predict possible active compound combinations Liza Vinhoven Received Received
  P-026 Characterisation of F508del-CFTR rescue by corrector MCG1516A Mafalda Bacalhau Received Received
  P-027 Identification of corrector combinations to increase the rescue of F508del-CFTR traffic and function Filipa Castela Ferreira Received Received
  P-028 Identification of novel F508del-CFTR correctors among triazole derivative compounds Mafalda Bacalhau Received Received
  P-029 First report: Kaftriovs. Symkeviin intestinal organoids Eva Furstova Received Received
  P-030 Metabolomic impact of the restoration of CFTR activity in the respiratory epithelium Emmanuelle Bardin Received Received
  P-031 The last 10: small molecule screening for correctors of rare CFTR processing mutations Marjolein Ensinck Received Received
  P-032 Chemical optimisation of a PI3Ky competing peptide for the therapy of cystic fibrosis Angela Della Sala Received Received
  P-033 Therapeutic approach by translational suppression of non-sens mutation in CFTR gene Sabrina Karri Received Received
  P-034 Novel insights into the therapeutic potential of antisense oligonucleotides as splicing modulators in respiratory and intestinal patient-derived model systems Noemie Stanleigh Received Received
  P-035 iPSC-derived macrophages from cystic fibrosis patients as a cell source to establish in vitro infection models and a drug screening platform Claudio Rodríguez-González Received Received
  P-036 Analysis of the dysfunction of cystic fibrosis macrophages Claudio Rodríguez-González Received Received
  P-037 Elexacaftor/tezacaftor/ivacaftor improve lung disease in patients with advanced cystic fibrosis homozygous for the F508del mutation Donatello Salvatore Received Received
  P-038 An Italian centre experience with elexacaftor-tezacaftor-ivacaftor therapy in cystic fibrosis patients with advanced lung disease Chiara Rosazza Received Received
  P-039 The clinical impact of triple CFTR modulator therapy in a cohort of people with CF and severe lung disease Orla Fanthorpe Received Received
  P-040 Compassionate use triple therapy CFTR modulation (Kaftrio) in severe disease. Single-centre, real-world clinical outcomes, safety and tolerability David Morrissy Received Received
  P-041 Effect of thetriplecombination of CFTR correctors and potentiatoron lung function, BMI and the Brasfield score in adolescents with cystic fibrosis Marina Praprotnik Received Received
  P-042 RECOVER - the Real World Clinical Outcomes with Novel Modulator therapy combinations in people with cystic fibrosis Paul McNally Received Received
  P-043 A snapshot of respiratory microbiology results pre- and post-commencing Kaftrio Laura Jenkins Received Received
  P-045 Are people with cystic fibrosis reducing their medication since Kaftrio initiation? Michael Dooney Received Received
  P-046 Menstrual abnormalities linked to Kaftrio Michael Dooney Received Received
  P-047 Impact of tezacaftor/ivacaftor/elexacaftor on outcome in a patient with I336Kmutation and a minimal function mutation R553X Sivagurunathan Sutharsan Received Received
  P-048 Olfactory dysfunction: impact of highly effective modulator therapy Daniel Beswick Received Received
  P-049 Tolerance induction (hyposensitisation) in drug intolerance to CFTR modulators Patience Eschenhagen Received Received
  P-050 Drug desensitisation for lumacaftor/ivacaftor - step-by-step to drug tolerance Julia Westhoff Received Received
  P-051 Rollout of Kaftrio to adult cystic fibrosis patients at the Royal Brompton Hospital during a global pandemic Elaine Bowman Received Received
  P-052 Managing the roll out of the cystic fibrosis modulator therapy Kaftrio at a large UK adult centre Constance (Connie) Takawira Received Received
  P-053 Real-life clinical effects of therapy with lumacaftor and ivacaftor in patients with cystic fibrosis Isabella Comello Received Received
  P-054 Clinical outcomes in people with cystic fibrosis treated with lumacaftor/ivacaftor in routine clinical practice in Sweden Anders Lindblad Received Received
  P-056 Intestinal current measurement (ICM) in cystic fibrosis paediatric patients - a pilot study Magdalena Postek Received Received
  P-057 Cystic fibrosis children not eligible for modulators therapy - data from a tertiary paediatric centre in Northwest United Kingdom Ghulam Mujtaba Received Received
  P-058 The effect of hypertonic saline treatment in preschoolers with cystic fibrosis on lung structure as measured by chest computed tomography (CT). SHIP-CT study: feasibility of CT scan protocol Harm A.W.M. Tiddens Received Received
  P-059 A double-blind randomised multicentre European study of linoleic acid supplementation for one year in patients with cystic fibrosis Birgitta Strandvik Received Received
  P-060 Phage therapy for chronic Pseudomonas aeruginosa infections in cystic fibrosis patients Maya Kahan-Hanum Received Received
  P-061 The UK Clinical Trials Accelerator Platform - a national cystic fibrosis clinical trials network increasing access to clinical trials for the UK cystic fibrosis community Rebecca Brendell Received Received
  P-062 Impact of the SARS-CoV-2 pandemic on clinical trials in the ECFS-CTN during 2020 Fiona Dunlevy Received Received
  P-063 Community involvement in shaping cystic fibrosis clinical trials Lorna Allen Received Received
  P-064 How does early weight gain explain the effect of childhood socioeconomic conditions on lung function for children with cystic fibrosis? A UK Registry-based study Daniela Schlter Received Received
  P-066 Lung function and pulmonary exacerbations among individuals with cystic fibrosis living near composting facilities in the United Kingdom Muhammad Saleem Khan Received Received
  P-067 Mechanisms for the effect of CFRD on mortality: a causal mediation analysis using UK cystic fibrosis Registry data Kamaryn Tanner Received Received
  P-068 Estimating the long-term effects of insulin on outcomes in cystic fibrosis-related diabetes: a target trial approach Emily Granger Received Received
  P-069 Cystic fibrosis-related liver disease a decade of experience Ana Mocic Pavic Received Received
  P-070 Epidemiology of nontuberculous mycobacteria in a single adult cystic fibrosis centre Ayesha Kumar Received Received
  P-071 Real-world pregnancy data and outcomes in an era post-CFTR modulation therapies: an Irish centres perspective Anina Ratjen Received Received
  P-072 Psychometric validation of the Cystic Fibrosis Impact Questionnaire: a patient-reported outcome instrument assessing the life impacts of cystic fibrosis Daniel Serrano Received Received
  P-073 Influence of assessment tool and publication type on the reported prevalence of depression and anxiety in adults with cystic fibrosis: a meta-analysis Louise Lord Received Received
  P-074 Setting up a framework for the collection of patient-reported outcomes in the real world: trials and tribulations Elise Lammertyn Received Received
  P-075 Are there lessons to be learned from cystic fibrosis patient deaths and the timing of lung transplant referral? Kavita Dave Received Received
  P-076 Using the Cystic Fibrosis Foundation consensus guidelines to assess the timing of lung transplant referral for individuals with cystic fibrosis in a single large adult UK centre: do they help? Kavita Dave Received Received
  P-077 Clinical factors affecting timing of referral for lung transplantation for people with cystic fibrosis: a national comparison of opinions between adult cystic fibrosis and transplant centres Kavita Dave Received Received
  P-078 The burden of cystic fibrosis beyond medical costs in Switzerland Christina Tzogiou Received Received
  P-079 Using a learning health system to understand medicine waste in cystic fibrosis the Easy Medicines for Burden Reduction And Care Enhancement (EMBRACE) study Amanda Bevan Received Received
  P-081 30 years of organisation of care for cystic fibrosis patients in the Russian Federation Yuliya Melyanovskaya Received Received
  P-082 The National Cystic Fibrosis Patient Registry of the Russian Federation 9 years of experience (2011-2019) Nataliya Kashirskaya Received Received
  P-083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study Elliot McClenaghan Received Received
  P-084 The impact of the SARS-CoV-2 pandemic on people living with cystic fibrosis in Ireland: real-world data from the Irish cystic fibrosis registry Huw Rees Received Received
  P-085 Impact of COVID-19 on hospital services and specialist care of adults with cystic fibrosis Rini Bhatnagar Received Received
  P-086 The impact of COVID-19 in people with cystic fibrosis a single-centre experience Georgina Aldous Received Received
  P-087 Impact of COVID-19 on mental health of children with cystic fibrosis and their parents Rini Bhatnagar Received Received
  P-088 Impact of COVID-19 and cocooning on employment of people with cystic fibrosis Rini Bhatnagar Received Received
  P-089 Coronavirus infection (COVID 19) in children with cystic fibrosis of the Russian Federation Yuliya Melyanovskaya Received Received
  P-090 A UK survey on changes in managing people with cystic fibrosis during the COVID-19 pandemic Saffana Hameed Received Received
  P-091 Regularity of check-ups at the cystic fibrosis centre in the time of COVID-19 pandemic Ivana Todori&263; Received Received
  P-092 Embedding an electronic patient record into a developing UK service and impact during the COVID-19 pandemic - Blackpool Adult Cystic Fibrosis Service (BACFS) Natasha Pickering Received Received
  P-094 Facilitating cystic fibrosis research during the COVID-19 pandemic Sharon Burnett Received Received
  P-095 Effect of age and genotype on lung function in children with cystic fibrosis Shadrina Vera Received Received
  P-096 Long-term follow-up of adolescent and adult patients with cystic fibrosis: a single centres experience Asl&305; &304;mran Y&305;lmaz Received Received
  P-097 Whos talking about cystic fibrosis? The changing landscape of internet postings related to cystic fibrosis: a two-year comparative study Tamara Vagg Received Received
  P-098 Change in FEV1 after standardised care algorithm for cystic fibrosis patients: quality improvement project Muruvvet Cenk Received Received
  P-100 Quality of home spirometry performance amongst adults with cystic fibrosis Jody Bell Received Received
  P-101 Provision of home spirometry in a physiologist-led service: experiences from a large adult cystic fibrosis centre Scott Hawkes Received Received
  P-102 Utility of Dynamic Chest Radiography (DCR) for calculating lung volume subdivisions in adult people with cystic fibrosis Thomas Simon FitzMaurice Received Received
  P-103 Longitudinal SF6 multiple breath washout testing in children aged 0-4 years with cystic fibrosis Rikke Sandvik Received Received
  P-104 Multiple-breath nitrogen washout test and structural lung damage in adult patients with cystic fibrosis Alexander Cherniak Received Received
  P-105 Lung clearance index in monitoring response to antibiotic therapy in children with cystic fibrosis Katarzyna Walicka-Serzysko Received Received
  P-106 Positioning may not affect lung clearance index TJ BAKER Received Received
  P-107 Lung clearance index in Bulgarian patients with cystic fibrosis Boryana Gospodinova Received Received
  P-108 Cross-sectional and longitudinal comparison of N2 and SF6 multiple breath washout in children with cystic fibrosis aged 2-45 months Rikke Sandvik Received Received
  P-109 Regional assessment of lung function using non-contrast MRI in people with cystic fibrosis Jonathan Brooke Received Received
  P-110 A soft, flexible, wearable device for cough detection in paediatric cystic fibrosis patients Andreas Tzavelis Received Received
  P-111 CT-signs and the effectiveness of surgical treatment of sinonasal disease in children with cystic fibrosis Yulia Gorinova Received Received
  P-112 Sleep disorders and exercise capacity in adult patients with cystic fibrosis in the Republic of North Macedonia Tatjana Jakovska Maretti Received Received
  P-113 Integration of Qi Gong sessions into a respiratory rehabilitation program: the experience of the CF Centre in Roscoff (France) Laetitia Gueganton Received Received
  P-114 Neutrophil effector responses to cystic fibrosis clinical isolates of Pseudomonas aeruginosa Kayla Fantone Received Received
  P-115 Effectiveness of different eradication treatment protocols for the first Pseudomonas aeruginosa isolation in paediatric cystic fibrosis patients Birce Sunman Received Received
  P-116 Clinical characteristics of frequent and infrequent pulmonary exacerbations of cystic fibrosis lung disease Claire Houston Received Received
  P-118 Lung ultrasound in cystic fibrosis exacerbations Ioana Ciuca Received Received
  P-119 Improving Home IV outcomes Christina Ryan Received Received
  P-120 Bridging the gap enhancing a multidisciplinary team Home IV service to reduce discrepancy in cystic fibrosis care Victoria Kendall Received Received
  P-121 The effect of training about nebuliser cleaning and disinfection on the knowledge levels and practises of the caregivers of patients with cystic fibrosis Muruvvet Cenk Received Received
  P-122 The role of the clinical pharmacy specialist in monitoring adherence to inhaled therapies in patients with cystic fibrosis in the Republic of North Macedonia Marija Atanasova Nadzinska Received Received
  P-123 Adaptive immune response to Mycobacterium abscessus complex and cross-reactivity of BCG vaccination Renan Mauch Received Received
  P-124 Implementing an anti-emetic protocol improves morbidity associated with intravenous therapy for Mycobacterium abscessus in children Anupama Menon Received Received
  P-125 Impact of infection withAchromobacterspp.on clinical outcome in paediatric patients with cystic fibrosis Birce Sunman Received Received
  P-127 Pulsed intravenous methylprednisolone for allergic bronchopulmonary aspergillosis in cystic fibrosis Tamsin Thornton Received Received
  P-128 A review of inhaled corticosteroid prescribing in an adult cystic fibrosis population Claire McKeown Received Received
  P-129 Induced sputum as a minimally invasive sample to investigate airway inflammation in the early course of cystic fibrosis Vincent Giacalone Received Received
  P-130 Chronic inflammation biomarkers and lung function in cystic fibrosis patients Mihaela Dediu Received Received
  P-132 The Induced Immune response in CF patients Mads Lausen Received Received
  P-133 Impact of specialised pro-resolving lipid mediators on cystic fibrosis airway epithelial cell functions Malle Briottet Received Received
  P-134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multicentre prospective study with a control group Carla Colombo Received Received
  P-136 Relationship between cystic fibrosis disease severity and susceptibility to COVID-19 infection MERVE ATALAY Received Received
  P-137 COVID-19 in cystic fibrosis patients with and without lung transplantation: the Zurich cohort Carolin Steinack Received Received
  P-139 Evaluating the impact of a telemedicine service during the COVID-19 pandemic in people with cystic fibrosis Alex Bull Received Received
  P-140 TeCC (TeleMedicine, Cystic Fibrosis, Corona-Virus) study in a previous telemedicine-naive centre: clinical challenges, outcomes, and user experience in the first six months of a global pandemic David Morrissy Received Received
  P-142 Lung and gut microbiota signatures in cystic fibrosis mice challenged with Pseudomonas aeruginosa Annamaria Bevivino Received Received
  P-145 Unwanted effects of an essential oil component, citral, on the susceptibility of Pseudomonas aeruginosato antibiotics Alexandre Tetard Received Received
  P-146 Intra-patient evolution of a pulmonary strain of Pseudomonas aeruginosa,from primocolonisation until after lung transplant Susie Gaillot Received Received
  P-148 Different treatment regimens in first isolation of Pseudomonas aeruginosa Cansu Yilmaz Yegit Received Received
  P-149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosaclinical isolates from people with cystic fibrosis Callum Sloan Received Received
  P-150 Competitive fitness experiments of CF isolates of Pseudomonas aeruginosa in human and murine precision-cut lung slices (PCLS) Lion Wege Received Received
  P-151 Improved isolation yields for bacteriophage active against Staphylococcus aureus Joshua Iszatt Received Received
  P-152 Clinical findings and long-term effect of methicillin-resistant Staphylococcus aureus isolation in patients with cystic fibrosis Beste Ozsezen Received Received
  P-153 Exophiala dermatitidis infection in cystic fibrosis patients accelerates lung function decline: a retrospective single-centre review of historical lung function Gemma Ford Received Received
  P-154 Exophiala dermatitidis can undergo patient-patient transmission in cystic fibrosis patients Jonathan Ayling-Smith Received Received
  P-155 Identification of an evolutionary split in Burkholderia multivorans using phylogenomics: does it have any impacts on the ability to cause cystic fibrosis lung infection? Kasia Parfitt Received Received
  P-156 Mycobacterium abscessus treatment in adult patients with cystic fibrosis: case series and review Amel Alameeri Received Received
  P-157 Monitoring the distribution and genotypic diversity of Burkholderiales bacteria in Russian cystic fibrosis patients in the year of the COVID-19 pandemic Olga Voronina Received Received
  P-158 Fungal airway colonisation in cystic fibrosis patients in the Institute for Respiratory Diseases in Children - Skopje, Republic of North Macedonia Ivana Arnaudova Danevska Received Received
  P-159 Relationship between clinical and environmental strains of emerging opportunistic pathogens in cystic fibrosis and diversity in the home environment Quentin Menetrey Received Received
  P-160 Detection and management of non-tuberculous mycobacteria in cystic fibrosis patients in a tertiary paediatric centre Harriet Wayman Received Received
  P-162 Pneumococcal and influenza vaccination coverage level: data from a cystic fibrosis centre Elpis Hatziagorou Received Received
  P-163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany Daniela Dolce Received Received
  P-164 What is the tolerance of antibiotic dry powder inhalers in patients with cystic fibrosis? Paul Wilson Received Received
  P-165 Improvement in antibiotic usage and ppFEV1 with compassionate use of elexacaftor, tezacaftor and ivacaftor (ETI) for patients with cystic fibrosis Olivia Baker Received Received
  P-166 Prevalence of cystic fibrosis-associated liver disease in Albanian cystic fibrosis patients Irena Kasmi Received Received
  P-167 Prevalence of liver disease in cystic fibrosis patients in the Institute for Respiratory Diseases in Children - Skopje, Republic of North Macedonia Ivana Arnaudova Danevska Received Received
  P-168 Use of faecal elastase in patients with cystic fibrosis and mutation analysis in the Republic of North Macedonia Tatjana Jakovska Maretti Received Received
  P-169 Trends in Glycaemic Control in a Cohort of Patients with Cystic Fibrosis Related Diabetes Rahana Khanam Received Received
  P-170 Current status of cystic fibrosis-related diabetes in the Bulgarian cystic fibrosis population GUERGANA PETROVA Received Received
  P-171 Adult cystic fibrosis diabetes patient education and care needs: have your say - a patient survey Katrin Kosbab-Jackson Received Received
  P-172 Patient experience of Manchester Virtual Cystic Fibrosis-Related Diabetes Clinic during the COVID-19 pandemic Amanda Brennan Received Received
  P-173 Investigation of cyproheptadine as an appetite stimulator in 6 children with cystic fibrosis with a suboptimal nutritional status Sara Van Meerbeeck Received Received
  P-174 The association between body composition and respiratory outcomes for patients with cystic fibrosis Lidia Sheibani Received Received
  P-175 Nutritional status, lung function and adequacy of micronutrient supplementation in children with cystic fibrosis Tena Niseteo Received Received
  P-176 The benefits of changing to a cystic fibrosis-specific combined fat-soluble vitamin supplement: vitamin status, tablet burden and adherence Katie Marsden Received Received
  P-177 A review of vitamin levels in children with cystic fibrosis following the introduction of a multi-vitamin preparation harriet gledhill Received Received
  P-180 Food access challenges and social needs for people with cystic fibrosis Cristen Clemm Received Received
  P-181 Nutrition support at an adult cystic fibrosis centre Mandisa Mitchell-Whyte Received Received
  P-182 Developing a model for self-care support of diet and the gut in the routine care of children with cystic fibrosis: a qualitative study Laurie Cave Received Received
  P-183 The role of the nutritionist in care of adult patients with cystic fibrosis in Republic of North Macedonia Sonja Panovska Received Received
  P-184 Going green: patient awareness of inhaler indication, usage and environmental impact Kizzy Snow Received Received
  P-185 Health literacy in children with cystic fibrosis Cherie Millar Received Received
  P-186 The use of Recombinant human DNase in a large adult cystic fibrosis centre: a quality improvement review Alison Orr Received Received
  P-187 Measuring the effect of airway clearance in adults with cystic fibrosis a systematic review Gemma Stanford Received Received
  P-188 Non-invasive ventilation use and management of adult cystic fibrosis patients at end of life Lucy E Wadsworth Received Received
  P-189 Impact of triple CFTR modulation therapy on non-invasive ventilation use in adults with cystic fibrosis Lucy E Wadsworth Received Received
  P-190 Adherence 50 to prescribed nebulisers in children with cystic fibrosis is associated with increased hospital admissions and lower FEV1 Z-Score Kieren James Lock Received Received
  P-191 The use of technology and web-based exercise programmes to improve engagement and quality of exercise sessions delivered to paediatric inpatients during an admission Louisa Wallbridge Received Received
  P-192 The introduction of a quality improvement focus group in a large UK adult cystic fibrosis centre Jocelyn Choyce Received Received
  P-193 Audit of cough swab sampling techniques in children with cystic fibrosis Zoe Johnstone Received Received
  P-194 Implementation of a cystic fibrosis-specific virtual pulmonary rehab program Catherine Fordyce Received Received
  P-195 Using remote access musculoskeletal consultations within a cystic fibrosis specialist physiotherapy service: a pilot Becky Dunphy Received Received
  P-196 Evaluation of the efficiency of Frequencer and Vest airways clearance devices in adult cystic fibrotic patients Peter Borka Received Received
  P-197 Dysglycaemia and changes in aerobic function in cystic fibrosis Owen Tomlinson Received Received
  P-198 Physical activity is associated with aerobic capacity and lung function in adults with cystic fibrosis Maire Curran Received Received
  P-199 Assessing the effectiveness of a six-month partially supervised outpatient exercise programme for adults with cystic fibrosis: a service evaluation Ann Banks Received Received
  P-200 Supporting exercise services in cystic fibrosis: five years of the UK CF & Exercise Network Owen Tomlinson Received Received
  P-201 The effectiveness of exercise interventions to increase physical activity in cystic fibrosis: a systematic review Maire Curran Received Received
  P-202 The evaluation of sinonasal and health symptoms in children with cystic fibrosis on Orkambi or Symkevi using the SNOT-22 Gemma Murray Received Received
  P-203 Fertile ground: pregnancies in a post-Kaftrio pandemic era Aoife Lillis Received Received
  P-204 The what-ifs....considering the psychological impacts of CFTR modulators Michele Puckey Received Received
  P-205 Patient-reported outcome measures in the current context of new generation modulator therapies in cystic fibrosis Kate Hayes Received Received
  P-206 Patient feedback following the introduction of a dedicated Symkevi Initiation Clinic prior to starting modulator therapy Lynette Haigh Received Received
  P-207 Depression and inflammation in people with cystic fibrosis: a pilot study Fabiana Ciciriello Received Received
  P-208 Anxiety, depression and resilience during COVID-19 in Dutch patients with cystic fibrosis or primary ciliary dyskinesia and their caregivers Marieke Verkleij Received Received
  P-209 Key priorities in mental health research: results of a community and provider survey across the US Beth Smith Received Received
  P-210 COACH project - screening for psychological comorbidity in adolescents with cystic fibrosis Svenja Temming Received Received
  P-211 Use of telemedicine for mental health screening during the COVID-19 pandemic Heather Bruschwein Received Received
  P-212 Understanding (the experiences of) how mindfulness is used by people with cystic fibrosis: barriers and enablers Sophia Kauser Received Received
  P-213 Can we attend anywhere? Evaluation of multi-disciplinary team (MDT) remote consultations Lisa Morrison Received Received
  P-214 Virtual cystic fibrosis doctor: design, development, and user experience pilot study David Morrissy Received Received
  P-215 Contrasting patient and paediatric cystic fibrosis team perception of telemedicine consultations Ema Kavaliunaite Received Received
  P-217 Delivering quality improvement coaching in a virtual world: the use of digital technology to empower and engage CFDigiCare clinicians to undertake quality improvement activities nationally Charlotte Carolan Received Received
  P-218 Detection of anxiety and depression through mental health screening questionnaires in cystic fibrosis patients and their families during the COVID-19 pandemic Ana Morales Tirado Received Received
  P-219 Before and during the COVID-19 pandemic: a review of health of our paediatric cystic fibrosis patients Lois Powell Received Received
  P-220 Experiences of virtual cystic fibrosis clinics during the Covid-19 pandemic at one UK adult cystic fibrosis centre Louise Warnock Received Received
  P-221 Quality of life in adult and children with cystic fibrosis during the COVID-19 pandemic in Croatia Tihana Odobasic Palkovic Received Received
  P-222 Supporting children with cystic fibrosis: building social networks through the pandemic Ellie Mindel Received Received
  P-223 The role of psychologist in a cystic fibrosis centre during the COVID-19 pandemic experience of a Polish paediatric centre Urszula Borawska-Kowalczyk Received Received
  P-224 Change in care during the COVID-19 pandemic: single-centre experience in a middle-income setting Ilektra Toulia Received Received
  P-225 Parents feedback on virtual paediatric cystic fibrosis clinics during Covid-19 pandemic Rachel Evans Received Received
  P-226 A survey of family experience of cystic fibrosis care during the COVID-19 pandemic Jill Watkinson Received Received
  P-227 Cystic fibrosis social workers experience of working during COVID-19 Fiona Dowdall Received Received
  P-228 Concerns for people with cystic fibrosis when travelling pre-COVID-19 Cherie Millar Received Received
  P-229 Children and young people with cystic fibrosis enhanced multi-disciplinary pathways to address their educational needs during the evolving COVID-19 pandemic Chandran Suja Received Received
  P-230 A review of paediatric cystic fibrosis care during the COVID-19 pandemic Lois Powell Received Received
  P-231 Patient experience of accessing a virtual cystic fibrosis service during the 2020 SARS-CoV-2 pandemic in Blackpool, North West of England Tarek Saba Received Received
  P-232 The impact of COVID-19 on the relationships between parents of young people diagnosed with cystic fibrosis and the cystic fibrosis multidisciplinary team Steve Jones Received Received
  P-233 Treatment outcome preferences among people with cystic fibrosis: a discrete choice experiment Rory Cameron Received Received
  P-234 CFHealthHub a digital learning health system supporting virtual clinics and self-care across 60 of UK adult CF centres: a survey to understand benefits amongst the national CFDigiCare community Josie Cunningham Received Received
  P-235 Using a 1,500-patient learning health system (LHS) to support virtual clinics and medicines optimisation: a UK seven-centre Patient and Public Involvement (PPI) project to understand user experience Sophie Dawson Received Received
  P-236 Quantifying the under-served or hard to reach but reachable people with cystic fibrosis (CF) in two UK adult CF centres Sophie Dawson Received Received
  P-237 The role of beliefs in predicting adherence to nebulised medications in adolescents with cystic fibrosis Bronwyn Stirzaker Received Received
  P-238 EMBRACEing Medicines Optimisation: working collaboratively to identify barriers and share solutions in the medication pathway across 12 sites within the CFHealthHub Charlotte Carolan Received Received
  P-239 Pulmonary medication adherence among children and adults with cystic fibrosis Elpis Hatziagorou Received Received
  P-240 Improving the accuracy of nebulizer prescriptions (and update where necessary) during the medication reconciliation process on CFHealthHub (within 24-hours) Rianna White Received Received
  P-241 Middle-aged cystic fibrosis patients experiences of living with cystic fibrosis: a qualitative study Lena Backstrm Eriksson Received Received
  P-242 Ageing with cystic fibrosis: how do older adults with cystic fibrosis adapt to change? Steven Stirk Received Received
  P-243 The psychological impact of the late diagnosis of atypical cystic fibrosis patients Guergana Petrova Received Received
  P-244 Moving from paediatric to adult care: resources to support transition Jacqueline Ali Received Received
  P-246 Transition in cystic fibrosis: international trends Daniel Office Received Received
  P-247 Improved quality of care increases lung function and growth parameters in children with cystic fibrosis Fabien Beaufils Received Received
  P-248 Patient Science: a new citizen science approach for health and medical research involving people affected by cystic fibrosis Johanna Gardecki Received Received
  P-249 Mens health in cystic fibrosis in the modern era: a qualitative study Traci Kazmerski Received Received
  P-250 Correlation between care allowance levels and antibiotic treatment at the Stockholm Cystic Fibrosis Centre Eleonora Falk Received Received
  P-251 The experience of adults with cystic fibrosis engaging in a complex health management regime: a meta-ethnography Steven Stirk Received Received
  P-252 Evaluation of a dashboard-style 1-page coloured CF annual review summary as a novel feedback method to improve communication with families and aid MDT working. Alison Coates Received Received
  P-253 Share the Sunshine to Improve Staff Wellbeing Sarah Simmons Received Received
  P-254 Development of a primary palliative care model that includes a novel approach to address the needs of caregivers of adults with cystic fibrosis - improving life with cystic fibrosis: a primary palliative care partnership Anna Georgiopoulos Received Received
  P-255 Parenthood experience of cystic fibrosis patients and their spouses - An explorative study Anne Jacob Received Received
  P-256 Waiting for double lung transplantation: psychological impact (review) Trudy Havermans Received Received
  P-257 Directions of psychological and pedagogical support of children with cystic fibrosis Sviridova Tatiana Received Received
  P-258 Integrating a diabetes service within the Adult Cystic Fibrosis Service at Blackpool Victoria Hospital, UK Julie Knowles Received Received
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 09/06/2021 TO 09/06/2022
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert